BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 14633696)

  • 1. Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer.
    Mutaguchi K; Yasumoto H; Mita K; Matsubara A; Shiina H; Igawa M; Dahiya R; Usui T
    Cancer Res; 2003 Nov; 63(22):7717-23. PubMed ID: 14633696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer.
    Sprenger CC; Damon SE; Hwa V; Rosenfeld RG; Plymate SR
    Cancer Res; 1999 May; 59(10):2370-5. PubMed ID: 10344746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer.
    Chen Y; Pacyna-Gengelbach M; Ye F; Knösel T; Lund P; Deutschmann N; Schlüns K; Kotb WF; Sers C; Yasumoto H; Usui T; Petersen I
    J Pathol; 2007 Mar; 211(4):431-8. PubMed ID: 17236181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human prostate cancer expresses the low affinity insulin-like growth factor binding protein IGFBP-rP1.
    Degeorges A; Wang F; Frierson HF; Seth A; Chung LW; Sikes RA
    Cancer Res; 1999 Jun; 59(12):2787-90. PubMed ID: 10383131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong suppression of tumor growth by insulin-like growth factor-binding protein-related protein 1/tumor-derived cell adhesion factor/mac25.
    Sato Y; Chen Z; Miyazaki K
    Cancer Sci; 2007 Jul; 98(7):1055-63. PubMed ID: 17465992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of IGFBP-rP1 increases radiosensitivity and chemosensitivity in hormone-refractory human prostate cancer.
    Seki M; Teishima J; Mochizuki H; Mutaguchi K; Yasumoto H; Oka K; Nagamatsu H; Shoji K; Matsubara A
    Hiroshima J Med Sci; 2013 Mar; 62(1):13-9. PubMed ID: 23600329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
    Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
    Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of insulin-like growth factor-binding protein-related protein-1 in prostate cells.
    Hwa V; Tomasini-Sprenger C; Bermejo AL; Rosenfeld RG; Plymate SR
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4355-62. PubMed ID: 9851777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium.
    López-Bermejo A; Buckway CK; Devi GR; Hwa V; Plymate SR; Oh Y; Rosenfeld RG
    Endocrinology; 2000 Nov; 141(11):4072-80. PubMed ID: 11089538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1/mac 25) is reduced in human prostate cancer and is inversely related to tumor volume and proliferation index in Lucap 23.12 xenografts.
    Tennant MK; Vessella RL; Sprenger CC; Sikes RA; Hwa V; Baker LD; Plymate SR
    Prostate; 2003 Jul; 56(2):115-22. PubMed ID: 12746836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor gene insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) induces senescence-like growth arrest in colorectal cancer cells.
    Ma Y; Lu B; Ruan W; Wang H; Lin J; Hu H; Deng H; Huang Q; Lai M
    Exp Mol Pathol; 2008 Oct; 85(2):141-5. PubMed ID: 18701096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo.
    Devi GR; Sprenger CC; Plymate SR; Rosenfeld RG
    Prostate; 2002 May; 51(2):141-52. PubMed ID: 11948969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1.
    Plymate SR; Haugk KH; Sprenger CC; Nelson PS; Tennant MK; Zhang Y; Oberley LW; Zhong W; Drivdahl R; Oberley TD
    Oncogene; 2003 Feb; 22(7):1024-34. PubMed ID: 12592389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis.
    Rubin J; Chung LW; Fan X; Zhu L; Murphy TC; Nanes MS; Rosen CJ
    Prostate; 2004 Jan; 58(1):41-9. PubMed ID: 14673951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells.
    Stewart LV; Weigel NL
    Prostate; 2005 Jun; 64(1):9-19. PubMed ID: 15651061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
    Enokida H; Shiina H; Igawa M; Ogishima T; Kawakami T; Bassett WW; Anast JW; Li LC; Urakami S; Terashima M; Verma M; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Cancer Res; 2004 Sep; 64(17):5956-62. PubMed ID: 15342374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor binding protein-related protein 1 inhibits proliferation of MCF-7 breast cancer cells via a senescence-like mechanism.
    Wilson HM; Birnbaum RS; Poot M; Quinn LS; Swisshelm K
    Cell Growth Differ; 2002 May; 13(5):205-13. PubMed ID: 12065244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
    Miyake H; Nelson C; Rennie PS; Gleave ME
    Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.